382 related articles for article (PubMed ID: 28476434)
41. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
[TBL] [Abstract][Full Text] [Related]
42. Nomograms predicting long-term overall survival and cancer-specific survival in head and neck squamous cell carcinoma patients.
Ju J; Wang J; Ma C; Li Y; Zhao Z; Gao T; Ni Q; Sun M
Oncotarget; 2016 Aug; 7(32):51059-51068. PubMed ID: 27419636
[TBL] [Abstract][Full Text] [Related]
43. Combined modality treatment outcomes for head and neck cancer: comparison of postoperative radiation therapy at academic vs nonacademic medical centers.
George JR; Yom SS; Wang SJ
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1118-26. PubMed ID: 24051518
[TBL] [Abstract][Full Text] [Related]
44. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
[TBL] [Abstract][Full Text] [Related]
45. Second primary lung cancers following a diagnosis of primary head and neck cancer.
Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S
Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386
[TBL] [Abstract][Full Text] [Related]
46. Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer.
Graboyes EM; Garrett-Mayer E; Ellis MA; Sharma AK; Wahlquist AE; Lentsch EJ; Nussenbaum B; Day TA
Cancer; 2017 Dec; 123(24):4841-4850. PubMed ID: 28841234
[TBL] [Abstract][Full Text] [Related]
47. Patterns of Recurrence in Electively Irradiated Lymph Node Regions After Definitive Accelerated Intensity Modulated Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
van den Bosch S; Dijkema T; Verhoef LC; Zwijnenburg EM; Janssens GO; Kaanders JH
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(4):766-74. PubMed ID: 26972649
[TBL] [Abstract][Full Text] [Related]
48. Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer.
Nordsmark M; Overgaard J
Acta Oncol; 2004; 43(4):396-403. PubMed ID: 15303502
[TBL] [Abstract][Full Text] [Related]
49. Treatment Package Time in Node-Positive Cutaneous Head and Neck Squamous Cell Carcinoma.
Daniels CP; Bressel M; Corry J; Cole A; Chua MS; Tiong A; Hirshoren N; Dixon B; McDowell L
Pract Radiat Oncol; 2020; 10(1):29-35. PubMed ID: 31606546
[TBL] [Abstract][Full Text] [Related]
50. Outcomes of cutaneous squamous cell carcinoma of the head and neck with parotid metastases.
McDowell LJ; Tan TJ; Bressel M; Estall V; Kleid S; Corry J; Johnston ML
J Med Imaging Radiat Oncol; 2016 Oct; 60(5):668-676. PubMed ID: 27324298
[TBL] [Abstract][Full Text] [Related]
51. Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma.
Abgral R; Le Roux PY; Rousset J; Querellou S; Valette G; Nowak E; Turzo A; Tissot V; Marianowski R; Salaün PY
Nucl Med Commun; 2013 Jun; 34(6):551-6. PubMed ID: 23587836
[TBL] [Abstract][Full Text] [Related]
52. Radical radiotherapy in head and neck squamous cell carcinoma: an analysis of prognostic and therapeutic factors.
Dinshaw KA; Agarwal JP; Ghosh-Laskar S; Gupta T; Shrivastava SK
Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):383-9. PubMed ID: 16817329
[TBL] [Abstract][Full Text] [Related]
53. IMRT/VMAT for malignancies in the head-and-neck region : Outcome in patients aged 80.
Brown ML; Glanzmann C; Huber G; Bredell M; Rordorf T; Studer G
Strahlenther Onkol; 2016 Aug; 192(8):526-36. PubMed ID: 27306747
[TBL] [Abstract][Full Text] [Related]
54. Elderly patients with squamous cell carcinoma of the head and neck and the benefit of multimodality therapy.
Moye VA; Chandramouleeswaran S; Zhao N; Muss HB; Weissler MC; Hayes DN; Zevallos JP
Oncologist; 2015 Feb; 20(2):159-65. PubMed ID: 25582139
[TBL] [Abstract][Full Text] [Related]
55. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
56. A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer.
Fury MG; Lee NY; Sherman E; Lisa D; Kelly K; Lipson B; Carlson D; Stambuk H; Haque S; Shen R; Kraus D; Shah J; Pfister DG
Cancer; 2012 Oct; 118(20):5008-14. PubMed ID: 22415650
[TBL] [Abstract][Full Text] [Related]
57. Prognostic value of 18F-fludeoxyglucose uptake in 287 patients with head and neck squamous cell carcinoma.
Rasmussen JH; Vogelius IR; Fischer BM; Friborg J; Aznar MC; Persson GF; Håkansson K; Kristensen CA; Bentzen SM; Specht L
Head Neck; 2015 Sep; 37(9):1274-81. PubMed ID: 24801812
[TBL] [Abstract][Full Text] [Related]
58. Comorbidity and performance status as independent prognostic factors in patients with head and neck squamous cell carcinoma.
Wang JR; Habbous S; Espin-Garcia O; Chen D; Huang SH; Simpson C; Xu W; Liu FF; Brown DH; Gilbert RW; Gullane PJ; Irish JC; Goldstein DP; Liu G
Head Neck; 2016 May; 38(5):736-42. PubMed ID: 25521753
[TBL] [Abstract][Full Text] [Related]
59. Pretreatment prognostic factors influencing distant metastasis-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy.
Jeremić B; Miličić B
Am J Clin Oncol; 2009 Oct; 32(5):483-7. PubMed ID: 19506455
[TBL] [Abstract][Full Text] [Related]
60. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy.
Rudat V; Dietz A; Schramm O; Conradt C; Maier H; Flentje M; Wannenmacher M
Radiother Oncol; 1999 Nov; 53(2):119-25. PubMed ID: 10665788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
